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During hemolysis, macrophages in the liver phagocytose damaged erythrocytes to prevent 
the toxic effects of cell-free hemoglobin and heme. It remains unclear how this homeostatic 
process modulates phagocyte functions in inflammatory diseases. Using a genetic mouse 
model of spherocytosis and single-cell RNA sequencing, we found that erythrophagocytosis 
skewed liver macrophages into a unique anti-inflammatory phenotype that we defined as 
Marco​high ​/Hmox ​high ​/MHC-class II ​low​ erythrophagocytes. This phenotype transformation 
profoundly mitigated disease expression in a model of an anti-CD40-induced 
hyperinflammatory syndrome with necrotic hepatitis and in a non-alcoholic steatohepatitis 
model, representing two macrophage-driven sterile inflammatory diseases. We reproduced 
the anti-inflammatory erythrophagocyte transformation in vitro by heme-exposure of 
mouse and human macrophages, yielding a distinctive transcriptional signature that 
segregated heme-polarized from M1- and M2-polarized cells. Mapping 
transposase-accessible chromatin in single cells by sequencing (scATAC-seq) defined the 
transcription factor NFE2L2/NRF2 as a critical driver of erythrophagocytes, and 
Nfe2l2​/ ​Nrf2​-deficiency restored heme-suppressed inflammation. Our findings point to a 
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Introduction 
The archetypical functions of macrophages are their roles as sensors, effectors, and 
resolvers of inflammation and tissue damage ​(1) ​. Historically defined as inflammatory 
M1-like and anti-inflammatory M2-like, macrophage phenotypes and functions are 
regulated by ontogeny and by tissue- and disease-specific triggers that regulate innate 
immune responses and tissue repair following injury ​(2, 3)​. Macrophages also play a key role 
in physiological erythrocyte turnover by mediating phagocytic clearance of senescent and 
damaged red blood cells (RBC). This homeostatic function of macrophages becomes 
imperative in conditions with enhanced erythrolytic stress such as in patients with an 
acquired or genetic hemolytic anemia ​(4) ​. 
RBCs, or erythrocytes, typically compartmentalize hemoglobin and heme within their 
anti-oxidative intracellular space. However, in conditions with pathological erythrolysis 
(5–7) ​, this protective compartmentalization is lost, and RBC toxins accumulate in tissue and 
plasma. Cell-free hemoglobin and heme cause adverse physiological effects by nitric oxide 
depletion, free radical reactions, and heme-triggered inflammation via Toll-like receptor 
engagement ​(8–18) ​. These disease-accelerating effects of uncontrolled erythrolysis are 
prevented by erythrophagocytosis, whereby macrophages recognize and phagocytose 
damaged RBCs before they disintegrate within the circulation ​(19–21)​. In conditions with 
systemic hemolysis such as in sickle cell disease, spherocytosis, after the transfusion of 
stored blood or during sepsis, this function is provided by macrophages in the liver ​(19) ​.  
Cell culture experiments and immunophenotyping in human tissues have demonstrated that 
erythrophagocytosis supports the differentiation of specialized macrophages with high 
antioxidant and iron-metabolizing capacity, suggesting that adaptation of the myeloid cell 
compartment provides tolerance against the toxicity of hemolysis ​(22–32)​. In vitro studies 
with human monocyte-derived macrophages found hemoglobin or heme-exposure 
repressed inflammatory responses and immunophenotype markers of activation ​(22–25)​. So 
far, it remains unanswered whether these effects of altered RBC homeostasis and heme 
metabolism on phagocytes could also change regulatory macrophage functions in the 
context of inflammatory diseases. Here, we hypothesized that enhanced demand for RBC 
clearance in individuals with a genetic or acquired hemolysis changes the macrophage 
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phenotype landscape in vivo and diverges the progression of macrophage-driven 
non-infectious inflammatory diseases. 
Nuclear erythroid 2 p45-related factor 2 (NFE2L2/NRF2) is a redox-sensitive basic leucine 
zipper transcription factor and the principal regulator of oxidative stress defense ​(33–36)​. 
More recently, NRF2 has gained attention as a negative regulator of inflammatory disease 
processes ​(37–40)​. NRF2 can suppress inflammation by at least four mutually interacting 
mechanisms including modulation of reactive oxygen species-dependent signaling ​(37, 41)​, 
transcriptional repression ​(42) ​, interference with NF-κB ​(43) ​, post-transcriptional 
modulation of inflammatory signaling genes ​(44, 45)​, or via enhancement of ​Hmox1 ​(46, 47)​.  
In the present study, we provide a global in vivo definition of the phenotype of 
erythrophagocytic macrophages, which we termed erythrophagocytes. We define these 
cells as a unique macrophage type with an anti-inflammatory gene signature driven by 
sustained activation of a heme-NFE2L2/NRF2 signaling pathway. Using a mouse model of 
hereditary spherocytosis and single-cell RNA sequencing (scRNA-seq) of mouse liver 
macrophages, we discovered that erythrophagocytosis forces the transformation of liver 
macrophages into an anti-inflammatory phenotype. As a result, we found in two models of 
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RESULTS 
Identification of ‘erythrophagocytes’ in the liver of hemolytic mice  
We used a mouse with a spontaneous truncation of the erythrocyte-specific cytoskeletal 
protein Spectrin-⍺ ( ​Spta ​sph/sph​) ​(48) ​ as an in vivo model of erythrophagocytosis to 
characterize the phenotype and inflammatory function of erythrophagocytic macrophages, 
which we term here erythrophagocytes. ​Spta ​sph/sph​ mice exhibited chronic hemolytic anemia 
with hyperbilirubinemia ( ​Figure 1A ​) resulting from a structural membrane instability leading 
to enhanced RBC clearance by phagocytes in the liver ​(49) ​. Using flow cytometry with 
corresponding imaging, we identified a large population of F4/80 ​+​ macrophages in the livers 
of ​Spta ​sph/sph​ mice that were also positive for ingested TER119 ​+ ​erythrocytes (​Figures 1B and 
C ​). In a histological analysis, the large F4/80 ​+ ​erythrophagocytes impressed as the 
predominant macrophage population in the liver of ​Spta ​sph/sph​ mice ( ​Figure 1D ​). Automatic 
counting of F4/80 ​+​ cells in the liver sections revealed a higher number of macrophages in 
the hemolytic than in the wild-type mouse ​(Supplementary Figure 1A)​. 
 
Erythrophagocytes have an antioxidant and anti-inflammatory transcriptional phenotype 
To assess the phenotype of erythrophagocytes in ​Spta ​sph/sph​ mice, we performed single-cell 
RNA-sequencing analysis (scRNA-seq) on macrophages that were enriched from 
nonparenchymal liver cell suspensions with anti-F4/80 antibody-coated Dynabeads. ​Figure 
1E​ shows a t-distributed stochastic neighbor embedding (t-SNE) plot of scRNA-seq data from 
an ​Spta ​wt/wt​ mouse and an ​Spta ​sph/sph​ mouse. In these data, we could recapitulate the 
presence of a large population of erythrophagocytes in the ​Spta ​sph/sph​ hemolytic mouse by 
visualizing the mRNA expression of hemoglobin ​ (Hba-a1) ​, which stems from remnant mRNA 
in phagocytosed RBCs. To support this interpretation, we confirmed by RT-qPCR that ​Hba-a1 
transcripts were highly abundant in leukocyte-depleted circulating RBCs of Spta mice. 
Accordingly,​ ​while only a small population of ​Hba-a1 ​-positive cells was observed in the 
Spta ​wt/wt​ mouse, almost all macrophages were ​Hba-a1 ​-positive in the ​Spta ​sph/sph​ hemolytic 
mouse. In addition, we found a small population of ​Hba-a1/Gypa ​ (Ter-119) double-positive 
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macrophages ( ​Figure 1E​), which likely represent erythroblastic island macrophages (EBIs) 
that phagocytosed the nuclei of RBC progenitors ​(50) ​. 
Further analysis and visualization of the liver macrophage scRNA-seq data was performed 
on the merged data sets from ​Spta ​wt/wt​ and ​Spta ​sph/sph​ ​mice ( ​Figure 1F ​).  Unsupervised 
graph-based clustering grouped the 17,127 cells into 17 populations ( ​Figure 1G ​). The 
cell-type identity of each cell cluster was determined by matching its gene expression profile 
with ex-ante defined marker genes for Kupffer cells (KCs), EBIs ​(51, 52)​, and early recruited 
macrophages as well as hepatocytes and endothelial cells ( ​Figures 1H ​and ​ 1I ​and 
Supplementary Figure 1B​) ​(53–59)​. 
The volcano plot in ​Figure 2A ​ illustrates the results of a differential gene expression analysis 
of KCs from the ​Spta ​sph/sph​ ​mouse (i.e., erythrophagocytes) and KCs from the ​Spta ​wt/wt 
littermate (​Supplementary Excel file 1​). Among the most overexpressed genes in liver 
macrophages from ​Spta ​sph/sph​ mice were marker genes of the erythrophagocytic process (​Hb 
and ​Alas2 ​), genes known to be induced by heme exposure ( ​Hmox1 ​ and ​Spic ​), oxidative 
stress-responsive genes (​Fth1 ​, ​Ftl1 ​, and ​Prdx1​), and cell surface receptor genes (​Marco ​ and 
Vcam1 ​). In contrast, ​MHC-class II-associated genes ( ​Cd74 ​ and several ​H2​ genes) were most 
downregulated. Accordingly, gene set enrichment analysis (GSEA) using the hallmark gene 
sets of the Molecular Signature Database (MSigDB) ​(60) ​ identified heme metabolism, the 
reactive oxygen species pathway, and oxidative phosphorylation as the most upregulated 
processes. In contrast, genes associated with allograft rejection and IFN alpha/gamma 
responses were the most downregulated, suggesting that erythrophagocytes in the livers of 
Spta ​sph/sph​ mice have an anti-inflammatory phenotype ( ​Figure 2B ​and ​Supplementary Figure 
7A​).  Visualizations of the gene expression differences on a single-cell level between 
Spta ​sph/sph​ and ​Spta ​wt/wt​ mice for ​Hmox1 ​, ​Marco ​, and ​Vcam1 ​ as well as the MHC-class 
II-associated genes ​Cd74 ​, ​H2-Aa​ and ​H2-Ab1​ are shown in ​Figure 2C ​. 
Among the intrinsic macrophage genes, we identified macrophage receptor with 
collagenous structure ( ​Marco ​) as the most upregulated gene in the ​Spta ​sph/sph​ mouse. ​Figure 
2D ​ shows a 2-dimensional density plot of mRNA count data summarizing the key phenotype 
characteristics that we identified for the erythrophagocytes in the ​Spta ​sph/sph​ mouse as 
Marco​high ​/Hmox ​high ​/MHC-class II ​low​. Interestingly, we have also detected a small population 
of Hmox ​high ​/MHC-class II ​low​ macrophages in the ​Spta ​wt/wt​ mouse liver (encircled population in 
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Figure 2E ​and ​ 2F​). This population was also positive for ​Marco ​ ​expression coinciding with 
the erythrophagocytosis marker ​Hba-a1 ​ (double-positive in ​Figure 2F ​). To further 
characterize these physiological erythrophagocytes, we performed a differential gene 
expression analysis comparing ​Marco ​+​ KCs with the major KC population ( ​Marco ​negative​)  in 
the ​Spta ​wt/wt​ mouse liver ​ ​( ​Supplementary Figure 2​,​ Supplementary Excel file 2 ​). We found 
that these cells share their gene expression profile with the erythrophagocyte population of 
the ​Spta ​sph/sph​ hemolytic mouse.  
In order to identify potential drivers of gene expression in erythrophagocytes, we 
performed an enrichment analysis of the upregulated genes identified in ​Spta ​sph/sph 
macrophages for transcription factor target motifs using EnrichR ​(61) ​ and identified the 
most significant signal for the transcription factor NFE2L2/NRF2 ( ​Supplementary Figure 1C​). 
To confirm the above scRNA-seq data, we performed bulk RNA-sequencing (bulk RNA-seq) 
analysis of F4/80 ​+​ liver macrophages that were also isolated using anti-F4/80 
antibody-coated Dynabeads from three ​Spta ​sph/sph​ mice and three ​Spta ​wt/wt​ mice, and 
identified the same transcriptional signature for erythrophagocytes with strongly increased 
expression of ​Hmox1 ​, ​Marco ​, ​Spic ​, and ​Vcam1 ​, while MHC-class II-associated genes ​(Cd74, 
H2-Aa, H2-Ab1, H2-Eb1)​ were profoundly suppressed ( ​Supplementary Figure 3A​). The top 
2000 differentially expressed genes (DEGs) in ​Spta ​sph/sph​ versus ​Spta ​wt/wt​ macrophages 
( ​Supplementary Excel file 3​)  were subjected to hierarchical clustering to segregate them 
into 6 regulatory clusters defining hemolytic and non-hemolytic gene expression of liver 
macrophages ( ​Supplementary​ ​Figure 3B​,​ left ​). Enrichment analysis of transcription factor 
binding sites for each of the six gene clusters ( ​Supplementary Figure 3B​,​ right​) revealed that 
among the genes upregulated in the ​Spta ​sph/sph​ macrophages, the largest cluster was most 
significantly enriched for genes known to be regulated by NFE2L2/NRF2. A strong signal was 
also identified for GATA1, the master transcription factor of erythropoiesis. This is 
compatible with the detection of intrinsic erythrocyte-mRNA after RBC phagocytosis by 
erythrophagocytes. The down-regulated gene clusters were enriched for genes controlled 
by RFXAP, RFXANK, and RFX5, which are regulators of MHC-class II-associated genes. 
To further investigate mechanisms that may govern the differentiation of 
erythrophagocytes, we assessed genome-wide chromatin accessibility by single-cell 
ATAC-seq of ​Spta ​sph/sph​ versus ​Spta ​wt/wt ​liver macrophages. ​Figure 3 A ​shows an unsupervised 
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clustering analysis of 862 nuclei that were isolated after enrichment of F4/80 ​+​ cells from 
mouse livers. The nuclei segregated into 10 clusters based on the different peak fragments 
they displayed ( ​Supplementary​ ​Figure 4A ​). We assessed the pseudo-gene-expression for 
specific genes in each cell by summing the reads containing the gene body with its 
associated upstream promoter region. After examining the accessibility of canonical marker 
genes (​Supplementary Figure 4B​), we could attribute cell-type identities to each cluster 
( ​Figure 3B​) ​. ​ While early recruited macrophages of both genotypes appeared in the same 
cluster, KCs of ​Spta ​wt/wt ​and erythrophagocytes of ​Spta ​sph/sph ​were clearly separated from each 
other indicating a significantly different overall accessibility of their chromatin. Differential 
analysis of accessible transcription factor motifs in these two cell types ( ​Figure 3C ​) 
established the motif for NFE2L2/NRF2 (MA0150.2) as the second most significantly 
overrepresented hit in erythrophagocytes (​Figure 3D ​and ​ Supplementary Excel file 4​). 
scATAC-seq also confirmed reduced accessibility for the MHC-class II locus on chromosome 
17 and enhanced accessibility of the ​Marco ​and ​Hmox1 ​genes, which is compatible with the 
scRNA-seq data (​Figure 3E​).  
In summary, we identified a phenotype of Marco ​high ​/Hmox ​high ​/MHC-class II ​low 
erythrophagocytes that is characterized by NFE2L2/NRF2-driven gene expression. In the 
human liver, the expression of ​Marco ​ ​defines a subset of anti-inflammatory macrophages 
(62) ​. Therefore, our data suggest the existence of a physiological population of 
anti-inflammatory ​Marco ​+​ erythrophagocytes that expands dramatically in response to 
hemolytic stress, becoming the most dominant macrophage phenotype in the liver and 
potentially modulating innate-immunity functions. 
 
Erythrophagocytes have an anti-inflammatory function 
We examined erythrophagocyte functions in an in vivo mouse model of inflammation. To 
establish a suitable model where inflammation is macrophage-driven, we decided to target 
CD40 ​ ​( ​Figure 4A ​), a NF-kB-activating receptor on mononuclear phagocytes. Thirty hours 
after injection of an agonistic anti-CD40 antibody, wild-type mice developed a systemic 
inflammatory syndrome reminiscent to a macrophage activation syndrome ​(63, 64)​, which 
was characterized by a cytokine storm, activated coagulation with thrombosis in the liver 
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vasculature, and multifocal liver necrosis ( ​Figure 4B​). As a result of this liver necrosis, the 
mice had increased plasma levels of alanine aminotransferase (ALT), which we used as a 
biomarker for the disease process. Depletion of macrophages by clodronate liposomes 
completely prevented the disease phenotype as illustrated by the lack of ALT increase after 
antibody treatment ( ​Supplementary Figure 3D​), suggesting that the inflammatory condition 
seen in the model represents a macrophage-driven process. To conclusively validate the 
specificity of macrophage-driven inflammatory disease in this model, we generated a 
macrophage-specific conditional ​Cd40 ​ knockout mouse ( ​Cd40 ​flox/flox​ ​LysM-Cre ​). In comparison 
to ​Cd40 ​flox/flox​ littermates that exhibited increased ALT levels upon treatment with anti-CD40 
antibody, plasma ALT levels in ​Cd40 ​flox/flox​ LysM-Cre ​ remained unchanged with anti-CD40 
antibody treatment, indicating lack of inflammatory disease in the absence of 
CD40-expressing macrophages ( ​Figure 4C ​).  
Based on the above results, we concluded that the anti-CD40 model would be suitable to 
evaluate the specific effects of hemolytic stress and erythrophagocytosis on inflammatory 
macrophage functions in vivo, and accordingly administered anti-CD40 antibody to ​Spta ​sph/sph 
and ​Spta ​wt/wt​ mice. Compared to ​Spta ​wt/wt​ littermates, the anti-CD40 antibody-induced 
disease expression was significantly attenuated in ​Spta ​sph/sph​ mice. No ALT elevation ( ​Figure 
4D ​) ​ ​or ischemic infarcts ( ​Figure 4E​) ​ ​were observed in the livers of anti-CD40 
antibody-treated ​Spta ​sph/sph​ animals. While anti-CD40 antibody-treated ​Spta ​wt/wt​ mice 
exhibited increased plasma concentrations of CCL2, CCL3, IL-6, and TNF⍺ in comparison to 
saline-treated mice, plasma concentrations of these cytokines remained almost unchanged 
in anti-CD40 antibody-treated ​Spta ​sph/sph​ mice ( ​Figure 4F ​).  
We also characterized the CD40 ligation-induced transcriptome changes in F4/80 ​+​ liver 
macrophages isolated from anti-CD40 antibody-treated ​Spta ​sph/sph ​and ​Spta ​wt/wt​ mice by bulk 
RNA-seq. Macrophages from ​Spta ​wt/wt​ mice exhibited a broad inflammatory response upon 
anti-CD40 treatment, which was characterized by GSEA enrichment of hallmark gene sets 
associated with inflammation, TNF signaling, IFN signaling, ​ ​and allograft rejection ( ​Figure 4G 
and 4H ​and ​Supplementary Figure 7B​),​ ​as well as by expression of key inflammatory genes 
( ​Figure 4I​,​ Supplementary Excel File 6​). This CD40-stimulated macrophage transcriptional 
response was markedly suppressed in erythrophagocytes isolated from ​Spta ​sph/sph​ mice  
( ​Figure 4I​,​ Supplementary Excel file 7​). At baseline, ​Spta ​sph/sph​ macrophages displayed a 
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slight, statistically not significant reduction of ​Cd40 ​ expression compared to wild-type mice 
( ​Supplementary Figure 3C​). ​Cd40 ​ expression was induced in ​Spta ​wt/wt​ and in ​Spta ​sph/sph 
macrophages after antibody treatment, suggesting that the broad anti-inflammatory effect 
of erythrophagocytosis occurs downstream of the CD40 signaling pathway. This is also 
consistent with the observation that anti-CD40 antibody treatment further stimulated 
erythrophagocytosis by liver macrophages in ​Spta ​sph/sph ​mice ( ​Supplementary Figure 3E​).  
Taken together, these results suggest that erythrophagocytosis skews liver macrophages 
into an anti-inflammatory functional state. 
 
Heme-exposure of BM-derived macrophages in vitro replicates anti-inflammatory 
erythrophagocyte polarization 
Erythrophagocytosis leads to a steep increase in the intracellular concentration of the 
porphyrin metabolite heme, which is a known modulator of gene expression in 
macrophages and other cell types. Therefore, we performed a series of studies to test 
whether heme-exposure of macrophages in vitro could mimic the effects of hemolytic stress 
on macrophage phenotype and inflammatory function. 
We exposed BM-derived macrophages​ ​(BMDM) to heme-albumin complexes, IFNγ or IL-4 
for 72 hours, and studied their transcriptome profile by bulk RNA-seq ( ​Supplementary Excel 
files 8​,​ 9 ​and ​ 10​). Principal component analysis demonstrated that heme-polarized 
macrophages clearly segregated from IFNγ- and IL-4-polarized cells ( ​Figure 5A ​), suggesting 
that heme promotes an idiosyncratic macrophage phenotype that is different from classical 
M1 (IFNγ)- and M2 (IL-4)-polarized macrophages. GSEA for heme-treated BMDMs 
identified the strongest signals for upregulated reactive oxygen species pathway and 
glycolysis, while interferon responses were strongly suppressed ( ​Supplementary Figure 5B​, 
Supplementary Figure 7C​), as seen previously in the erythrophagocytes isolated from livers 
of ​Spta ​sph/sph​ mice. Macrophages stimulated with IL-4 or IFNγ exhibited distinct 
transcriptional profiles, indicating that they differentiated into divergent macrophage 
subsets, as illustrated by comparative enrichment analysis of key gene sets and transcription 
factors ( ​Supplementary Figure 5A​). mRNA expression count data for selected 
heme-response genes confirmed the induction of genes involved in the antioxidant 
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response and suppression of MHC-class II-associated genes ( ​Figure 5B​). In addition, a strong 
signal for the previously identified marker gene for erythrophagocytes, ​Marco ​, and for the 
gene expressing the heme-inducible transcription factor, ​Spic ​, was observed. Consistent 
with an authentic cell differentiation process, we found a progressive change in gene 
induction and suppression over 72 hours ( ​Supplementary Figure 5C​).  
As in erythrophagocytes of hemolytic mice, an EnrichR analysis of upregulated genes in 
heme-albumin-treated BMDMs for transcription factor target genes provided the most 
significant hit for genes regulated by NFE2L2/NRF2 ( ​Supplementary Figure 5A​). To test 
whether NRF2 activation alone could reproduce the phenotype transition induced by 
heme-albumin, BMDMs were differentiated in parallel with heme-albumin or with either of 
the two pharmacological NRF2 activators, RA-839 and ML-334 for 72 hours. The radar chart 
in ​Figure 5C ​ illustrates that key phenotype features of heme-polarized macrophages are 
mimicked by the NRF2 activators, including the upregulation of oxidative stress response 
genes and ​Marco, ​as well as profound downregulation of MHC-class 2 associated genes. 
Hmox1 ​and ​Spic ​are less induced by the NRF2 ​ ​activators compared to heme. This is 
congruent with the established function of the heme-responsive transcriptional repressor 
BACH1 in the regulation of these genes ( ​Figure 5C ​) ​(26, 65)​. Collectively, these data point to 
NFE2L2/NRF2 as a strong candidate signaling pathway transmitting key phenotypic features 
of erythrophagocytes. 
To establish that heme also drives anti-inflammatory erythrophagocyte function, we 
measured the mRNA expression of select inflammatory response genes by RT-qPCR using in 
vitro heme-polarized BMDMs subjected to LPS stimulation. The clustering analysis of mRNA 
gene expression data revealed a broad inflammatory response of BMDMs that were 
stimulated with LPS. In contrast, this LPS response was markedly suppressed in 
heme-polarized macrophages ( ​Figure 5D ​). However, under the same conditions the 
expression of heme-inducible genes, ​Hmox1 ​ and ​Spic ​, was significantly enhanced ( ​Figure 
5D ​), indicating the target specificity of the heme-transmitted signal. The anti-inflammatory 
effect of heme-albumin was also reflected by the reduced secretion of IL-12p40 and IL-6 
into the cell culture medium ( ​Figure 5E​). To exclude cytotoxicity of heme-albumin, such as 
that resulting from oxidative stress or ferroptosis, as a cause of the anti-inflammatory 
effect, we measured mitochondrial function and the glycolytic rate of BMDMs using a 
12 
 
Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Seahorse metabolic flux analyzer. Heme exposure for 72 hours did not change mitochondrial 
function, and enhanced, rather than suppressed, glycolytic activity ( ​Supplementary Figure 
5D ​), a finding that is ​ ​consistent with the increased expression of glycolysis-related genes 
identified in bulk RNA-seq data ( ​Supplementary Figure 7C​). 
Collectively, these results demonstrate that heme drives differentiation of BMDMs into 
erythrophagocyte-like cells, supporting a strong anti-inflammatory function. 
To translate our findings to human physiology, we have performed heme-exposure 
experiments with human macrophages that were differentiated from PBMCs of healthy 
blood donors and subjected to LPS. As in murine BMDMs, heme-exposure induced ​HMOX1 
and the NFE2L2/NRF2 target gene ​NQO1​, and the LPS-induced inflammatory response was 
significantly attenuated ( ​Figure 5F ​). However, the anti-inflammatory effect appeared to be 
more selective. While ​CXCL9 ​, ​CXCL10, ​ and ​IL12b ​were strongly suppressed by 
heme-albumin, we found only a weak effect on ​IL6 ​expression with high interindividual 
variability. This difference may be related to the more differentiated in vitro phenotype of 
PBMCs compared to mouse BMDMs. 
Heme-NRF2 signaling drives BMDM polarization into erythrophagocyte-like 
anti-inflammatory cells 
To further explore the potential role of NFE2L2/NRF2-mediated inflammatory suppression in 
response to heme we performed studies with BMDMs from ​Nrf2​ knockout mice ( ​Nrf2​-/-​). We 
first established that the absence of the transcription factor in BMDMs markedly reduced 
heme-induced mRNA expression of the NRF2 target genes ​Marco ​, ​Spic ​, ​Nqo1​, and ​Slc7a11 
( ​Figure 6A ​). In contrast, ​Hmox1 ​expression was not attenuated, reinforcing the critical 
function of BACH1 rather than NRF2 in its regulation by heme. Heme-induced NRF2 target 
gene expression and inflammatory suppression could be observed as early as after 4 hours 
of heme treatment. This short exposure period was chosen for experiments with ​Nrf2​-/- 
macrophages to minimize confounding effects that may occur due to unopposed oxidative 
stress during longer heme-exposures. ​Figure 6B​ shows a scatter plot of mRNA expression 
data from gene array experiments with wild-type ( ​Nrf2​+/+​) BMDMs treated with 
heme-albumin for 4 hours and LPS for an additional 4 hours. Based on unobserved 
clustering analysis, the genes upregulated in response to LPS treatment (green, total 271 
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genes) comprised a population that was distinct from the genes upregulated only in 
response to combined LPS and heme-albumin treatment (red, 57 genes) ( ​Figure 6B​, 
Supplementary Excel file 11​). An EnrichR analysis of these 57 heme-induced genes found 
again the most significant enrichment for genes that were regulated by NFE2L2/NRF2 
( ​Supplementary Figure 6A​). Experimentally, this gene cluster was less upregulated in 
BMDMs from ​Nrf2​-/- ​ mice. ​Supplementary Figure 6B​ shows the cumulative effect of 
heme-exposure on the LPS-induced inflammatory response in ​Nrf2​+/+​  and ​Nrf2​-/-​ BMDMs. 
The data suggest that the suppression of the LPS-induced genes by heme was less 
pronounced in the absence of NRF2.  
To further test the role of NRF2 in heme-induced inflammatory suppression, we performed 
a factorial analysis of these experiments with LPS-stimulated macrophages from ​Nrf2​+/+​ or 
Nrf2​-/-​ mice in the presence or absence of heme ( ​Figure 6C ​). The individual effects of heme 
and NRF2 in this model were calculated from the differential gene expression data 
( ​Supplementary Excel files 12 ​and ​ 13​) and the output data were analyzed by GSEA 
( ​Supplementary Figures 8A ​and ​ B​). A correlation plot of the GSEA enrichment scores (ESs) 
for all 50 hallmark gene sets suggested that heme (in wild-type macrophages) and NRF2 (in 
heme-exposed macrophages) have almost identical qualitative effects on macrophage 
polarization, which agrees with our hypothesis of a linked effector pathway ( ​Figure 6D ​, a 
correlation plot of the same effects on the individual gene level is shown in ​Supplementary 
Figure 6C)​. Overlay density plots of the running ESs for the most significant gene sets 
highlighted in ​Figure 6D ​ visualize equal induction of antioxidant pathways and glycolysis 
alongside a strong suppression of LPS-induced inflammatory responses by heme and NRF2 
( ​Figure 6E​). In accordance with the predicted positive effect of heme-NRF2 signaling on 
glycolysis-related gene expression, metabolic flux analysis revealed that in comparison to 
heme-albumin-treated ​ Nrf2​+/+​ BMDMs, the extracellular acidification rate (ECAR) was 
strongly attenuated in ​Nrf2​-/- ​ BMDMs even after maximal stimulation with oligomycin 
( ​Figure 6F ​).  
We confirmed the role of NRF2 in the anti-inflammatory function of heme in an 
independent set of experiments with BMDMs from ​Nrf2​+/+​ and ​Nrf2​-/-​ mice. 
Heme-albumin-mediated suppression of ​Il12b ​ and ​Il6 ​mRNA after LPS stimulation was not 
observed in ​Nrf2​-/-​ BMDMs ( ​Figure 6G ​). The key role of NRF2 is further supported by the 
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observation that also the anti-inflammatory effect of heme in BMDMs is mimicked by 
pharmacological activators of NRF2 ( ​Figure 6H​). 
Collectively, these results indicate that NRF2 is an important driver of heme-induced gene 
expression and anti-inflammatory polarization in macrophages, and may have a role in 
metabolic adaptation. 
Hemolytic mice exhibit tolerance against diet-induced nonalcoholic fatty liver disease 
We aimed to establish whether the anti-inflammatory function of erythrophagocytes has 
broader implications beyond specific exogenous inflammatory triggers such as anti-CD40 
antibodies and LPS, to impact more complex and multifactorial inflammatory disease 
processes. To this end, we examined the effect of erythrophagocyte expansion in the liver 
on the development of diet-induced nonalcoholic liver disease (NAFLD), a disease caused by 
metabolic dysregulation that induces KC activation with ​Tnf ​expression, inflammation, 
steatosis and hepatocellular damage ​(66–68)​. NAFLD was induced in ​Spta ​wt/wt​ and ​Spta ​sph/sph 
mice by feeding them a methionine- and choline-deficient (MCD) diet ​(69–71)​. At day 12 of 
the MCD diet, ​Spta ​wt/wt​ mice exhibited enhanced mRNA expression of ​Tnf ​ in the isolated 
F4/80 ​+​ liver macrophages, as well as increased plasma concentrations of ALT, and the 
macrophage chemokine CCL2 ( ​Figures 7B​). Compared to ​Spta ​wt/wt​ mice, these changes were 
mostly repressed in hemolytic ​Spta ​sph/sph​ mice. Liver histology revealed extensive steatosis in 
Spta ​wt/wt​, but not in ​Spta ​sph/sph​ mice fed the MCD diet ( ​Figures 7A and C​). In comparison to 
Spta ​wt/wt​ mice fed the MCD diet, a markedly expanded pool of F4/80 ​+​ erythrophagocytes was 
found in the livers of ​Spta ​sph/sph​ mice fed the MCD diet, which indicated that disease 
tolerance was a function of not a reduced number of macrophages but of an altered 
functional state ( ​Figure 7D ​). The treatment of wild-type mice with the NRF2 activator 
dimethyl fumarate (DMF), an approved drug for relapsing-remitting multiple sclerosis ​(35, 
38)​, mimicked the heme response and attenuated the increase of liver enzymes in MCD fed 




Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
DISCUSSION 
Using scRNA-seq studies of liver macrophages, we discovered a unique population of 
erythrophagocytes with an anti-inflammatory phenotype and function. Under hemolytic 
stress, these anti-inflammatory erythrophagocytes become the predominant macrophage 
population leading to a pronounced attenuation in two models of inflammatory liver 
disease. In vitro heme-exposure of BMDMs reproduced the Marco ​high ​/Hmox ​high ​/MHC-class 
II​low​ erythrophagocyte profile, yielding a transcriptional signature that segregated the 
heme-polarized macrophages from IFNγ-polarized (M1-like) and IL-4-polarized (M2-like) 
cells. This suggests that heme-polarized macrophages represent an idiosyncratic phenotype, 
providing on-demand adaptation to hemolytic stress.  
A defining feature of erythrophagocytes in our studies was the strong expression of the 
scavenger receptor Marco. In the human liver, the expression of ​Marco ​ segregates 
inflammatory (Marco ​low​) macrophages from anti-inflammatory (Marco​high ​) macrophages, 
which are characterized by an attenuated ​Tnf ​ expression response upon in vitro stimulation 
with LPS and IFNγ ​(62) ​. In alveolar macrophages, ​Marco ​ has a non-redundant 
anti-inflammatory function protecting against oxidative lung injury ​(72) ​. ​Enhanced ​Marco 
expression and the diminished expression of MHC-class II genes are also phenotypic 
characteristics of tumor-associated macrophages linked to reduced immunogenicity and 
immunosuppression in cancer ​(73) ​. ​ Marco​high ​/Hmox ​high ​/MHC-class II ​low​ erythrophagocytes in 
the liver appear to acquire similar anti-inflammatory functions. To support this assumption, 
we used an in vivo model of anti-CD40 antibody-induced systemic inflammation that had 
the advantages of a macrophage-driven disease process with a primarily liver-based 
pathology. By transforming inflammatory Kupffer cells into anti-inflammatory 
erythrophagocytes, mice with spherocytosis displayed a markedly attenuated disease 
response. Macrophages were numerous in the livers of ​Spta ​sph/sph​ mice before and after 
anti-CD40 antibody treatment. They exhibited enhanced erythrophagocytic activity 
alongside a gene expression profile that did not indicate nonspecific cell stress or activation 
of controlled death pathways suggesting that the profound anti-inflammatory function does 
not reflect a toxic response, but instead results from a divergent macrophage phenotype.  
Supporting our hypothesis of a broader role for the anti-inflammatory impact of 
heme-mediated macrophage polarization, we found in a model of nonalcoholic fatty liver 
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disease (NAFLD) that erythrophagocytes in the MCD-diet-fed ​Spta ​sph/sph​ mice expressed less 
Tnf ​, which coincided with low plasma levels of the disease-associated macrophage-derived 
chemokine CCL2 ​(68) ​, markedly reduced hepatocellular damage, and almost absent liver 
steatosis compared to wild-type mice on the same diet. As key integrators of endogenous 
and exogenous proinflammatory signals, Kupffer cells and recruited liver macrophages play 
a central role in the initiation and progression of NAFLD and nonalcoholic steatohepatitis 
(NASH) ​(74) ​. Several macrophage-specific interventions involving depletion of Kupffer cells 
(69, 71, 75)​, macrophage-selective knockout of pattern recognition receptor pathways ​(76, 
77)​, or macrophage-targeted delivery of anti-inflammatory drugs ​(78) ​ have successfully 
been used to interrupt NAFLD progression, with many of these approaches being 
particularly effective during the early disease phase ​(69) ​. 
The anti-inflammatory phenotype and function of erythrophagocytes are supported by the 
finding of NFE2L2/NRF2 ​- ​driven gene expression across our studies, which was consistent 
with the open chromatin landscape defined by scATAC-seq. Heme-induced antioxidant gene 
expression was significantly attenuated in ​Nrf2​ knockout macrophages. This finding 
supports the idea that heme acts as an activator of ​Nrf2​ in our model, as has been shown in 
human macrophages ​(79) ​ and in other cell types ​(80–82)​. Furthermore, the suppressive 
effect of heme on LPS-triggered inflammatory gene expression was rescued in ​Nrf2 
knockout macrophages.  
A limitation of our study is that we could not directly investigate the contribution of NRF2 to 
the anti-inflammatory heme polarization of macrophages in vivo ​. ​ This is due to the 
impossibility of experimentally dissociating the adaptive function of NRF2 activation from its 
anti-inflammatory activity. In other words, because NRF2 is indispensable to resist oxidative 
heme-stress in vivo, systemic toxicity with multiorgan failure overwhelms the 
anti-inflammatory effects of heme after experimental heme-exposure or during hemolysis in 
an ​Nrf2​ knockout mouse. Nevertheless, we found that the NRF2 activating drug DMF 
mimicked the effect of chronic hemolysis on NAFLD progression in our MCD model.  
In human macrophage cell cultures, heme activates liver-X-receptor (LXR)-coordinated gene 
expression, driving the differentiation of macrophages with a 
CD163​high ​/Hmox1 ​high ​/MHC-class II ​low​ immunophenotype that resembles the Mhem 
macrophages identified in microhemorrhage areas of atherosclerotic plaques ​(23–25, 83)​. 
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As a central integrator of metabolic and anti-inflammatory signaling, LXR activation may 
help consolidate the anti-inflammatory phenotype of erythrophagocytes ​(84) ​. In addition, 
heme and other porphyrins inhibit the proteasome and could, therefore, directly interfere 
with a key process of proinflammatory NF-κB activation ​(85, 86)​. Thus, it is likely that 
erythrophagocyte polarization by heme-induced NRF2 signaling is aided by a synergistic 
network that enables immune adaptation to hemolytic stress in a disease state- and tissue 
type-specific way. 
The heme-driven differentiation of macrophages into the stable anti-inflammatory state 
that we describe here needs to be distinguished from an intrinsic inflammatory activity of 
free heme that can be mediated by ligation of TLR4 on leukocytes and endothelial cells ​(9, 
10, 87)​. Our previous observations suggested that the way heme is presented to a cell may 
determine its ultimate effect on the innate immune system. In the case of 
erythrophagocytosis or with a protein-bound heme (e.g., as hemoglobin or albumin-bound 
heme) the metalloporphyrin is preferentially delivered for intracellular anti-inflammatory 
signaling. In contrast, free heme in the extracellular space may more avidly interact with 
pattern recognition receptors on the cell surface ​(88) ​. 
In conclusion, our findings suggest the existence of a pathway that links hemolysis and 
erythrophagocytosis with the regulation of inflammatory phagocyte functions. This concept 
may provide a basis for further research to understand immune dysfunction accompanying 
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METHODS 
A Supplementary Methods Section is available. 
 
Animal models 
Wild-type C57BL/6J mice were obtained from Charles River (Wilmington, MA, USA). ​Nrf2​-/- 
mice​ ​were obtained from Professor Yuet Wai Kan (University of California, San Francisco). 
Interbreeding of heterozygous ​Spta ​sph​ mice (B6.C3-Spta1 ​sph ​/BrkJ X WB.C3-Spta1 ​sph ​/BrkJ mice, 
Jackson Laboratory, Bar Harbor) yielded spherocytic and wild-type offspring. The ​Cd40 
targeted mouse strain used for this research project was created from ES cell clone 
EPD0901_3_A02, obtained from the KOMP Repository (www.komp.org) and generated by 
the Wellcome Trust Sanger Institute (WTSI, Hinxton, UK). Targeting vectors used were 
generated by the WTSI and the Children’s Hospital Oakland Research Institute as part of the 
Knockout Mouse Project (3U01HG004080). We crossed the gene-targeted ​Cd40 ​flox/flox​ mice 
with FLP recombinase mice that recognize the FRT site to remove the LacZ reporter and 
neomycin selection cassette. The spliced exons, which are flanked by loxP sites before ​Cd40 
exon 2 and after ​Cd40 ​ exon 3 were removed by crossing to the ​LysM-Cre ​ mouse, resulting in 
macrophage-specific ​Cd40 ​ knockout mice. Littermates without the ​LysM-Cre ​ driver were 
used as controls ​(89) ​. Strain appropriate controls were used across all the other 
experiments.   All mice were housed and bred under specific-pathogen-free conditions in 
the Laboratory Animal Services Center (LASC) of the University of Zürich. 8-10 weeks old 
males and females were used.  
 
Experimental details for the different animal models and treatments can be found in the 
Supplementary methods section (Agonistic anti-CD40 antibody-induced systemic 
inflammation and hepatitis model, Liposomal clodronate injections, MCD diet model, 
Dimethyl fumarate (DMF) treatment).  
 
Heme preparation for cell culture 
Hemin (heme-chloride) was obtained from Sigma (51280). The porphyrin was dissolved in 10 
ml of NaOH (100 mM) at 37°C, followed by addition of 10 ml of 20% human serum albumin 
(CSL Behring AG). After 1 hour of incubation at 37°C, the pH of the solution was adjusted to 
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pH 7.4 using ortho-phosphoric acid, and the final volume was brought to 25 ml with saline 
solution. The heme-albumin solutions were sterile-filtered (0.22 µm) and used immediately. 
 
Mouse BMDM and human monocyte-derived macrophage isolation and culture 
Mouse and human macrophages have been isolated and cultured according to standard 
protocols. Details can be found in the Supplementary Methods. 
 
In situ liver digestion of mouse livers and macrophage enrichment 
Liver digestion was performed with a protocol modified from Cabral ​et al ​ ​(90) ​. The 
abdominal cavity of a living, deeply anesthetized mouse was opened, and the portal vein 
was catheterized for ​in situ ​liver perfusion and digestion with collagenase B buffered 
solution (Roche, 11088815001). Once digested, livers were dissected out and the mouse 
was sacrificed. The digested livers were then mechanically disaggregated in a petri dish on 
ice and filtered through a 100 μm pore cell strainer. The cell suspensions were centrifuged 
twice at 60 x g for 2 min at 4°C, and the pellets were discarded. The supernatants were then 
centrifuged at 300 x g for 5 min at 4°C to obtain a pellet of nonparenchymal liver cells 
containing liver macrophages. ​ ​To select for F4/80 ​+​ macrophages from liver cell suspensions, 
Dynabeads Sheep anti-Rat IgG (Invitrogen, 11035), in combination with purified rat 
anti-mouse F4/80 antibody (BD Pharmingen, 0.5 mg/ml, 565409) ), and a DynaMag™-2 
Magnet (Thermo Fisher Scientific, 12321D) were used according to the manufacturer's 
positive selection protocol (Invitrogen).  
 
Flow cytometry sample preparation and analysis 
Flow cytometry has been performed according to standard protocols ​. ​ Cells were analyzed 
on ​ ​an LSRFortessa (BD) and on an ImageStream X Mk II Imaging Flow Cytometer (Amnis), 
respectively. Details (including antibodies) can be found in the Supplementary Methods. 
 
Sequencing based workflows 
Single-cell RNA sequencing​:​ F4/80 ​+​ nonparenchymal liver cells were processed for 
scRNA-seq according to the 10x Genomics Chromium Single Cell 3’ v3 workflow. Libraries 
were sequenced using the Illumina NovaSeq 6000 system according to 10X Genomics 
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recommendations. Details on cell processing, library production, sequencing, data analysis 
and visualization can be found in the Supplementary Methods. 
 
Bulk RNA sequencing and data analysis:​ Sequencing was performed using a standard 
workflow with an Illumina NovaSeq 6000 sequencer. Details can be found in the 
Supplementary Methods.  
 
Assay for Transposase Accessible Chromatin:​ ​ATAC-seq was performed using the Chromium 
Single Cell ATAC workflow (10x Genomics). Details on the isolation of nuclei, library 
preparation, sequencing and data analysis are described in the Supplementary Methods. 
Microarray experiments and data analysis 
We used whole-mouse or whole-human genome oligo microarrays (G4846A, 4 × 44 K, 
Agilent Technologies) as described ​(29) ​. ​Statistical analysis and visualization were performed 
with JMP Genomics 7.0 (SAS Institute). Details are provided in the Supplementary Methods. 
 
Real-time PCR 
RT-qPCR was performed according to a standard workflow on a  7500 Fast Real-Time PCR 
System (Applied Biosystems). Protoc details and a complete list of human and mouse 
primers can be found in the Supplementary Methods. 
 
Bio-Plex cytokine assays 
Concentrations of cytokines were determined with Bio-Plex Cytokine Assays (Bio-Rad). The 
assay was analyzed with a Bio-Plex 200 system (Bio-Rad). The results were analyzed using 
Bio-Plex Data Pro software (Bio-Rad). 
 
Mouse tissue histology 
Details on tissue preparation microscopy, imaging and data analysis can be found in the 
Supplementary Methods.  
 
Statistical analysis 
Data plotting and statistical analysis were performed with Prism 8 (GraphPad), JMP 13 (SAS), 
Bioturing SingleCell browser (v2.4.21), or R (v3.6.1) [ ​https://www.R-project.org/ ​]. RNA 
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count data was normalized and compared using either DESseq2 R package (v1.26.0) ​(91) ​ or 
EdgeR (v 3.30.0) ​(92, 93)​.  For group comparisons of other data types, we used ANOVA with 
Tukey’s post-test as indicated in the figure legends. For the analysis of human macrophage 
gene expression data, we used Kruskal-Wallis with the Wilcoxon post-test to account for the 
high variability with occasional outliers. All data points are displayed in the graphs. Boxplots 
display median and interquartile range, whiskers represent min and max values. *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001. 
 
Study approval 
All experimental protocols were reviewed and approved by the Veterinary Office of the 
canton of Zürich, Switzerland. Mice were treated in accordance with the guidelines of the 
Swiss Federal Veterinary Office. 
 
DATA SHARING STATEMENT 
For original data, please contact ​florence.vallelian@usz.ch ​. All next-generation sequencing 
and microarray data can be accessed via the following link: 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145244 ​ . All supplementary Excel 
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Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Figure 1 - Identification of erythrophagocytes in the liver of hemolytic mice 
 
A. Plasma bilirubin in ​Spta ​sph/sph​ and ​Spta ​wt/wt​ (WT) mice (n= 4 for both groups, n.m. = not 
measurable). 
B. Flow cytometry density plots of liver cell suspensions stained for F4/80 and 
intracellular TER119  in ​Spta ​sph/sph ​mice (red) and ​Spta ​wt/wt​ ​littermates (blue). The 
displayed cells were gated from live CD45 ​+​ leukocytes. Data are representative of 
three independent experiments. Percent proportions of cell counts are displayed in 
the plot. 
C. Brightfield and fluorescence images showing intracellular TER119 ​pos​ erythrocytes 
(yellow) in F4/80 ​pos ​Kupffer cells (KCs) (purple) from ​Spta ​wt/wt​ ​and  ​Spta ​sph/sph​ mice 
obtained by imaging flow cytometry. 
D. Top panel: ​Microphotographs of liver tissues stained for F4/80. ​Bottom panel: 
High-magnification microphotographs of F4/80 ​+​ macrophages from ​Spta ​wt/wt​ and 
Spta ​sph/sph​ ​mice. Data representative of three mice in each group. 
E. Single-cell RNA-sequencing (scRNA-seq) data of non-parenchymal liver cell 
suspensions enriched for macrophages with F4/80 antibody-coated magnetic 
Dynabeads from ​Spta ​sph/sph​ and ​Spta ​wt/wt​ mice. t-SNE plots showing color-coded 
Gypa ​/ ​Hba-a1 ​ gene expression in ​Spta ​wt/wt​ and ​Spta ​sph/sp​h ​mice. Double-positive cells 
are highlighted by the blue dashed line. Each dot represents a single cell. 
F. Data sets from the two mice shown in (E) are merged and represented in a single 
t-SNE plot, showing 17,127 cells colored by cell origin.  
G. Same tSNE as in (F). After an unsupervised clustering analysis, cells sharing similar 
transcriptome profiles are grouped by color. Seventeen clusters were identified. 
H. Heatmap of the average expression of key marker genes for hepatocytes, endothelial 
cells, erythroblastic island macrophages (EBIs), early recruited macrophages and KCs 
in each cluster. Data are standardized by row, z-scores are displayed by color code 
(red=high expression, blue=low expression). 
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Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Figure 2 - Antioxidant and anti-inflammatory transcriptional phenotype of 
erythrophagocytes 
A. Volcano plot demonstrating differential gene expression of KCs in ​Spta ​sph/sph​ versus 
Spta ​wt/wt ​mice (-log10(​p ​-value) versus log2-fold change). Among the positive 
differentially expressed genes (DEG), marker genes of the erythrophagocytic process 
are highlighted in red, genes associated with heme exposure and oxidative stress are 
highlighted in blue, and macrophage receptors are highlighted in green. The 
downregulated MHC-class II-associated genes are highlighted in purple. 
B. DEGs were computed by gene set enrichment analysis (GSEA). Enrichment plots of 
the top three positively (magenta) and negatively (blue) enriched hallmark gene sets 
are shown. Plots display running enrichment score and position of gene set members 
on the rank-ordered list. 
C. t-SNE plot showing all cells colored by cell origin. The expression of ​Hmox1 ​, ​Marco, 
Vcam1, Cd74, H2-Aa, ​and ​H2-Ab1​ is visualized in global t-SNE plots. Legend for 
relative log2 expression of each gene from lowest expression (blue dots) to the 
highest expression (red dots) is displayed on the top right. 
D. Contour plot showing the correlation of ​Hmox1 ​, ​Marco ​or ​H2-Aa ​and ​ Hba-a1 ​ count 
data from every cell in the ​Spta ​sph/sph​ (red) and ​Spta ​wt/wt​ ​(blue) mouse datasets. 
E. Contour plot showing the correlation of ​Hmox1 ​or​ H2-Aa ​and ​Marco ​ count data from 
every cell in the ​Spta ​sph/sph​ (red) and ​Spta ​wt/wt​ ​(blue) mouse datasets. 
F. t-SNE plots with color-coded expression of ​Marco ​and ​ Marco/Hba-a1 ​in ​Spta ​sph/sph 
(left) and ​Spta ​wt/wt​ (right) mice. The magenta dashed line highlights the 
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Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Figure 3 - Chromatin accessibility and transcription factor motif enrichment in 
erythrophagocytes  
Single-cell ATAC sequencing data of non-parenchymal liver cell suspensions enriched 
for macrophages with F4/80 antibody-coated magnetic Dynabeads from ​Spta ​sph/sph 
and ​Spta ​wt/wt​ mice. 
 
A. UMAP plots showing all cells colored by cell origin ( ​Spta ​sph/sph​ red, ​Spta ​wt/wt​ blue). 
B. UMAP plots showing all cells colored by cell type. Cell type was attributed based on               
the pseudo-gene expression of each cell for specific cell type markers displayed in             
Supplementary Figure 4B.  
C. Volcano plot displaying the results of the motif enrichment analysis in ​Spta ​sph/sph            
erythrophagocytes compared to ​Spta ​wt/wt KCs (red, 119 motifs in total) and ​Spta ​wt/wt            
KCs compared to ​Spta ​sph/sph ​erythrophagocytes (blue, 119 motifs in total).  
D. Position weight matrix plot of NFE2L2 motif (MA0150.2), BACH1 motif (MA0591.1),           
and ARNT motif (MA0004.1) from the JASPAR 2018 database with the corresponding            
p- ​value from the motif enrichment analysis.  
E. Coverage plots around the coding region for the genes ​H2-Aa (with 2000 kb             
upstream and downstream), ​H2-Eb1 (with 5000 kb upstream and downstream),          
Marco (with 20’000 kb upstream and downstream) and ​Hmox1 (with 20’000 kb            



































































































































































































































Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Figure 4 – Anti-inflammatory function of erythrophagocytes 
 
A. Schematic representation of experimental design: mice were treated with an 
agonistic anti-CD40 antibody for 30 hours (for macrophage isolation and blood 
removal) or 48 hours (for liver collection). 
B. Representative histology image for H&E staining of a thrombus with an ischemic liver 
infarct after treatment of ​Spta ​wt/wt​ ​mouse with anti-CD40 antibody. Scale bar 200 µm. 
C. Plasma alanine transaminase (ALT) concentrations in ​LysM-Cre Cd40 ​flox/flox​ ​(Cre +/-, 
knockout) or ​Cd40 ​flox/flox​ (Cre -/-, control) mice treated with saline or anti-CD40 
antibody (n=3-6).  
D. Plasma ALT concentrations in ​Spta ​wt/wt​ ​(WT, blue) and ​Spta ​sph/sph​ (Sph, red) mice 
treated with saline or anti-CD40 antibody (n=6-8).  
E. Photographs of representative liver lobes from ​Spta ​sph/sph​ ​and ​Spta ​wt/w​t ​mice treated 
with anti-CD40 antibody.  
F. Hierarchical clustering analysis of plasma cytokines from ​Spta ​sph/sph​ ​and wild-type 
littermates treated with anti-CD40 antibody (yellow=low concentration, red=high 
concentration) or saline. 
G. Bulk RNA-seq data of F4/80-enriched non-parenchymal liver cell suspensions from 
three ​Spta ​sph/sph​ and ​Spta ​wt/wt​ mice treated with anti-CD40 antibody or saline. 
Hierarchical clustering analysis of the 2000 top significant DEGs (rows) between the 
anti-CD40 and saline-treated ​Spta ​wt/wt​ (column). In total, 5803 DEGs were identified 
based on an absolute log2(Ratio) > 0.5 and ​p ​-value < 0.01 threshold. 
H. GSEA of DEGs of KCs in ​Spta ​wt/wt​ mice treated with anti-CD40 antibody versus saline. 
Enrichment plots of the top four positively enriched hallmark gene sets are shown. 
Plots display running enrichment score and position of gene set members on the 
rank-ordered list. 
I. Normalized count data for key inflammatory genes expressed in KCs from anti-CD40 
or saline (cont) treated ​Spta ​wt/wt​ (blue) and ​Spta ​sph/sph ​(red) mice.  
Each data point represents a single mouse; *** p<0.001, ** p<0.01, * p<0.05, ANOVA with 
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Pfefferle et al. Hemolysis induced anti-inflammatory erythrophagocytes 
Figure 5 - Replication of the anti-inflammatory erythrophagocyte polarization by 
heme-exposure of mouse BM-derived macrophages in vitro  
A. Mouse BM-derived macrophages (BMDMs) were exposed to either albumin 
(control), heme-albumin (200 and 400 µM), IFNγ (10 ng/ml) or IL-4 (10 ng/ml) for 
72 hours and then processed for bulk RNA-seq. Samples are plotted based on the 
first two principal components (n=3). 
B. Normalized count data for the expression of antioxidant genes, MHC-class 
II-associated genes, ​Marco,  Hmox1,​ and ​ Spic ​ in heme-albumin (200 and 400 µM) 
treated (magenta) and control BMDMs (gray). 
C. Radar plot of relative mRNA gene expression of antioxidant genes, MHC-class 
II-associated genes, ​Marco,  Hmox1, Spic ​ and inflammatory genes measured by 
RT-qPCR in BMDMs treated with albumin (control; gray), heme-albumin (200 µM; 
magenta), RA-839 (15 µM; blue) or ML-334 (50 µM; green) for 72 hours (n=4-8).  
D. Hierarchical clustering analysis of the relative mRNA expression of key inflammatory 
genes, ​Hmox1 ​ and ​Spic ​ measured by RT-qPCR in BMDMs treated or not with 
heme-albumin for 72 hours +/- LPS for an additional 4 hours (yellow=low expression, 
red=high expression) (n=4-5). 
E. Concentrations of IL-12p40 and IL-6 in cell culture medium measured by Bio-Plex in 
BMDMs treated or not with heme-albumin for 72 hours +/- LPS for an additional 4 
hours (n=3).  
F. Relative mRNA expression of key inflammatory genes, ​HMOX1,​ and ​NQO1​ measured 
by RT-qPCR in PBMCs-derived human macrophages treated or not with 
heme-albumin for 72 hours +/- LPS for an additional 4 hours (n=6).  
*** ​p ​<0.001, ** ​p ​<0.01, * ​p ​<0.05, ANOVA with Tukey’s post hoc test for panel E and 
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Figure 6 - Heme-NRF2 signaling drives erythrophagocyte-like polarization of BMDMs  
A. RT-qPCR expression data for heme-response genes in ​Nrf2​+/+ and ​Nrf2​-/- ​BMDMs after            
heme-albumin (200 µM) or albumin (control) treatment for 6 hours (mean of n=3             
replicates). 
B. Scatter plot of differentially expressed genes (log ​Ratio ​>0.5) of heme-albumin versus          
albumin treated BMDMs followed by LPS (4 hours). Data represent the log10 of the              
expression-ratio as mean from n=4 gene array experiments. A transcription factor           
enrichment analysis for the red-labeled gene cluster is displayed in Supplementary           
Figure 6A. 
C. Factorial layout and predicted phenotype outcomes of gene array experiments with 
BMDM from ​Nrf2​+/+​ and ​Nrf2​-/-​ ​mice that were treated with or without 
heme-albumin and LPS. Effects on differential gene expression for heme in wild-type 
cells (effect ​heme​) and for the ​Nrf2​ gene in heme-exposed cells (effect ​Nrf2​) were 
calculated by the displayed formulae. 
 
D. Correlation of the GSEA hallmark gene set enrichment scores for effect ​heme​ and 
effect​Nrf2​. The top three hallmark gene sets are highlighted (p<0.001). 
 
E. Overlaid GSEA enrichment score plots for the hallmark gene sets highlighted in (D). 
 
F. Heatmap of the ECAR of ​Nrf2​+/+​ and ​Nrf2​-/​-​ BMDMs. BMDM were treated for 4 hours 
with albumin (control) or with 200 µM heme-albumin before the Seahorse 
experiment. Cells were analyzed at baseline and after treatment with oligomycin. 
Mean values from three measurements per condition (yellow = low ECAR, red = high 
ECAR). 
 
G. LPS-stimulated ​Il6 ​ and ​Il12b ​ mRNA expression in ​Nrf2​+/+​ and ​Nrf2​-/-​ BMDMs after 
pretreatment with albumin or with heme-albumin (+h) for 4 hours (n=6-9), 
measured by RT-qPCR.  
 
H. Il12b, Nos2,​ ​Nqo1​ mRNA in wild-type BMDMs treated with LPS, LPS+heme, or with 
the ​Nrf2​ activators RA-839 and ML-334 measured by RT-qPCR. Mean from three 
independent experiments. 
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Figure 7 - Tolerance against diet-induced nonalcoholic fatty liver disease in hemolytic mice 
 
A. Scans of H&E stained liver lobe sections at 15x magnification (left) or 200x 
magnification (right) from ​Spta ​wt/wt​ (blue) and ​Spta ​sph/sph​ ​(red) mice fed a 
methionine-choline-deficient (MCD) or control diet for 12 days. The images 
displayed are representative of five animals in each group. 
B. Spta ​wt/wt​ (blue) and ​Spta ​sph/sph​ ​(red) mice that were fed a MCD or control diet for 12 
days. Top to bottom: mRNA expression of ​Tnf ​ in F4/80 ​+​ liver macrophages measured 
by RT-qPCR (n=3-7), plasma ALT (n=8-23) and CCL2 (n=3-5) concentrations. 
C. Quantitative morphometric analysis of the area with macrosteatosis in liver tissues 
(% of the total tissue area) based on liver histology images of the five mice 
mentioned in A (n=2-5).  
D. Microphotographs of liver tissues from MCD diet-fed ​Spta ​wt/wt​ and ​Spta ​sph/sph ​mice 
stained for F4/80 ​+​ macrophages. Scale bar 100 µm. 
E. Plasma ALT concentrations from ​Spta ​wt/wt​ mice treated with dimethyl fumarate 
(DMF) at 100 mg/kg (or vehicle control) for 7 days and then fed control or MCD diet 
for 12 days (n=3-6).  
Individual symbols represent one mouse; *** p<0.001, ** p<0.01, * p<0.05 for all panels, 
ANOVA with Tukey’s post hoc test.  
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